Cardiovascular safety of the glucagon-like peptide-1 receptor agonist taspoglutide in people with type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.06.009 ◽

2019 ◽

Vol 154 ◽

pp. 101-115 ◽

Cited By ~ 5

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Lorenzo Scappaticcio ◽

Miriam Longo ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of 21 randomized controlled trials

Endocrine ◽

10.1007/s12020-020-02193-9 ◽

2020 ◽

Vol 68 (3) ◽

pp. 508-517 ◽

Cited By ~ 2

Author(s):

Suhui Qie ◽

Xuejing Li ◽

Xianying Wang ◽

Yang Liu ◽

Jingxin Li ◽

...

Keyword(s):

Systematic Review ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting

Update in Cardiovascular Safety of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes—A Mixed Treatment Comparison Meta-analysis of Randomized Controlled Trials

Diabetes ◽

10.2337/db18-414-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 414-P

Author(s):

OSAMAH ALFAYEZ ◽

MAJED S. AL YAMI ◽

RAZAN ALSHEIKH

Keyword(s):

Meta Analysis ◽

Controlled Trials ◽

Mixed Treatment Comparison ◽

Cardiovascular Safety ◽

Treatment Comparison ◽

Randomized Controlled ◽

Mixed Treatment ◽

Glucagon Like Peptide ◽

Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Diabetes Care ◽

10.2337/dc16-1957 ◽

2017 ◽

Vol 40 (4) ◽

pp. 614-624 ◽

Cited By ~ 52

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Annalisa Capuano ◽

Katherine Esposito ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon-like peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-analysis of randomized controlled trials

Scientific Reports ◽

10.1038/s41598-017-16018-9 ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 4

Author(s):

Fang Zhang ◽

Lizhi Tang ◽

Yuwei Zhang ◽

Qingguo Lü ◽

Nanwei Tong

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Diabetes Patients

Faculty Opinions recommendation of Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733387640.793548846 ◽

2018 ◽

Author(s):

Marleen van Baak

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Vitamin D ◽

Meta Analysis ◽

Vitamin D Supplementation ◽

Controlled Trials ◽

Individual Participant Data ◽

Randomized Controlled ◽

Individual Participant

Erratum to: Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials

Acta Diabetologica ◽

10.1007/s00592-017-1049-z ◽

2017 ◽

Vol 54 (11) ◽

pp. 1069-1071

Author(s):

Ilaria Dicembrini ◽

Besmir Nreu ◽

Alessia Scatena ◽

Francesco Andreozzi ◽

Giorgio Sesti ◽

...

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon-like peptide-1 receptor agonists versus insulin glargine for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials

Current Therapeutic Research ◽

10.1016/j.curtheres.2010.08.003 ◽

2010 ◽

Vol 71 (4) ◽

pp. 211-238 ◽

Cited By ~ 20

Author(s):

Wei-Xin Li ◽

Jian-Feng Gou ◽

Jin-Hui Tian ◽

Xiang Yan ◽

Lin Yang

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials

American Journal of Clinical Nutrition ◽

10.1093/ajcn/nqy078 ◽

2018 ◽

Vol 107 (6) ◽

pp. 1043-1053 ◽

Cited By ~ 16

Author(s):

Karin MA Swart ◽

Paul Lips ◽

Ingeborg A Brouwer ◽

Rolf Jorde ◽

Martijn W Heymans ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Vitamin D ◽

Meta Analysis ◽

Vitamin D Supplementation ◽

Controlled Trials ◽

Individual Participant Data ◽

Randomized Controlled ◽

Individual Participant

Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials

Minerva Endocrinology ◽

10.23736/s0391-1977.20.03219-8 ◽

2020 ◽

Author(s):

Besmir Nreu ◽

Ilaria Dicembrini ◽

Federico Tinti ◽

Edoardo Mannucci ◽

Matteo Monami

Keyword(s):

Type 2 Diabetes ◽

Pancreatic Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽